One for the road! A study to assess the efficacy of single low-dose regimen of rasburicase in controlling hyperuricaemia in patients with tumour lysis syndrome due to haematological malignancies

We conducted a retrospective audit of six patients with various haematological malignancies (two acute lymphoblastic leukaemia, one acute myeloid leukaemia, and three non-Hodgkin lymphoma); these patients were eligible to receive rasburicase, being at high risk of development of tumour lysis syndrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Azim, Hamdy A, Bahr, Sherif Ahmed, Kamal, Nermine Shawky, Koura, Mohamed Adel, Tolba, Rehab, Gad, Heba Abdelmoneem, Morsy, Ahmad, Attia, Hossameldin Mohsen, Iskander, Ibraheem, Hammad, Ahmed, Hemed, Mohammed Farouk, Abdallah, Mohammed Fathy, Sadek, Kareem Ahmed, Taha, Alaa Hamdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855003/
https://www.ncbi.nlm.nih.gov/pubmed/24324529
http://dx.doi.org/10.3332/ecancer.2013.378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855003/
https://www.ncbi.nlm.nih.gov/pubmed/24324529
http://dx.doi.org/10.3332/ecancer.2013.378

Ejemplares similares